Biological
DC vaccination
DC vaccination is a biological therapy with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
40%
Ph phase_2
3
60%
Phase Distribution
2
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
3(60.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Active, not recruiting1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (40.0%)
Phase 23 (60.0%)
Trials by Status
unknown240%
completed120%
active_not_recruiting120%
not_yet_recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
not_yet_recruitingphase_1
Preventive Dendritic Cell Vaccination for Lynch Syndrome
NCT07412197
active_not_recruitingphase_1
Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI
NCT01885702
unknownphase_2
Ovarian Dendritic Cell Vaccine Trial
NCT00703105
unknownphase_2
Study of DC Vaccination Against Glioblastoma
NCT01567202
completedphase_2
Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients
NCT02285413
Clinical Trials (5)
Showing 5 of 5 trials
NCT07412197Phase 1
Preventive Dendritic Cell Vaccination for Lynch Syndrome
NCT01885702Phase 1
Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI
NCT00703105Phase 2
Ovarian Dendritic Cell Vaccine Trial
NCT01567202Phase 2
Study of DC Vaccination Against Glioblastoma
NCT02285413Phase 2
Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5